本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Cogent Biosciences, Inc.

10.86
-0.1100-1.00%
盤後11.070.2100+1.93%16:34 EDT
成交量:173.20萬
成交額:1,856.04萬
市值:15.15億
市盈率:-4.35
高:10.97
開:10.87
低:10.38
收:10.97
資料載入中...
2024/08/06

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report
2024/06/27

重要事件披露

Form 8-K - Current report
2024/06/13

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/05

重要事件披露

Form 8-K - Current report
2024/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/09

SEC問詢函

Form CORRESP - Correspondence
2024/04/01

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/27

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/22

重要事件披露

Form 8-K - Current report
2024/02/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/26

重要事件披露

Form 8-K - Current report
2024/02/16

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]